Request for Proposals
MRA is the largest non-profit funder of melanoma research. MRA’s investment in the field has been critical in catalyzing transformative, strategic, and collaborative investments in scientific discovery and translation.
Each year, MRA selects new research awards to address critical unmet needs in melanoma detection, prognostication, and treatment. All grant awards selected by MRA’s Grant Review Committee through a diligent peer review process and confirmed by the MRA Board of Directors. To date, MRA has invested over $110 million in life-saving melanoma research, in addition to $150 million in outside, leveraged funds.
MRA Request for Proposals:
- MRA General RFP - now closed
- MRA/ACS Special Opportunity RFP - now closed
- Dermatology Fellows Award - Pilot Program - now open
Tasheema Prince, MRA Scientific Program Manager
Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.